| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -85.85M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, APGE returned +252.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +78.5% |
| 1 year | +252.1% |
| All-time high | $134.75 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in APGE would be worth today ›No. Apogee Therapeutics, Inc. has not paid a dividend in the past 12 months.
Apogee Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol APGE.
Apogee Therapeutics, Inc. is part of the Healthcare sector.
Apogee Therapeutics, Inc. has a market cap of 10.20B USD, based on the latest quote.
Apogee Therapeutics, Inc. is expected to report earnings around Nov 9, 2026. That date is an estimate and has not been confirmed by the company.
